title: Identification of candidate agents active against N. ceranae infection in honey bees: establishment of a medium throughput screening assay based on N. ceranae infected cultured cells.
abstract: Many flowering plants in both natural ecosytems and agriculture are dependent on insect pollination for fruit set and seed production. Managed honey bees (Apis mellifera) and wild bees are key pollinators providing this indispensable eco- and agrosystem service. Like all other organisms, bees are attacked by numerous pathogens and parasites. Nosema apis is a honey bee pathogenic microsporidium which is widely distributed in honey bee populations without causing much harm. Its congener Nosema ceranae was originally described as pathogen of the Eastern honey bee (Apis cerana) but jumped host from A. cerana to A. mellifera about 20 years ago and spilled over from A. mellifera to Bombus spp. quite recently. N. ceranae is now considered a deadly emerging parasite of both Western honey bees and bumblebees. Hence, novel and sustainable treatment strategies against N. ceranae are urgently needed to protect honey and wild bees. We here present the development of an in vitro medium throughput screening assay for the identification of candidate agents active against N. ceranae infections. This novel assay is based on our recently developed cell culture model for N. ceranae and coupled with an RT-PCR-ELISA protocol for quantification of N. ceranae in infected cells. The assay has been adapted to the 96-well microplate format to allow automated analysis. Several substances with known (fumagillin) or presumed (surfactin) or no (paromomycin) activity against N. ceranae were tested as well as substances for which no data concerning N. ceranae inhibition existed. While fumagillin and two nitroimidazoles (metronidazole, tinidazole) totally inhibited N. ceranae proliferation, all other test substances were inactive. In summary, the assay proved suitable for substance screening and demonstrated the activity of two synthetic antibiotics against N. ceranae.
authors: Institute for Bee Research, Department of Molecular Microbiology and Bee Diseases, Hohen Neuendorf, Germany.
authors: Sebastian
authors: S
authors: Gisder
authors: Institute for Bee Research, Department of Molecular Microbiology and Bee Diseases, Hohen Neuendorf, Germany.
authors: Elke
authors: E
authors: Genersch
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D001516:Bees / Q000382:microbiology*; D003510:Cyclohexanes / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D008795:Metronidazole / Q000494:pharmacology; D016881:Microsporidiosis / Q000188:drug therapy / Q000662:veterinary*; D016818:Nosema / Q000187:drug effects / Q000502:physiology*; D012717:Sesquiterpenes / Q000494:pharmacology; D014011:Tinidazole / Q000494:pharmacology
chemical_list: D000935:Antifungal Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; D014011:Tinidazole; D008795:Metronidazole; C026211:fumagillin